Immunogenicity and safety of an adjuvanted inactivated polio vaccine, IPV-Al, in primary and booster trials in Asia, Central America and Europe

Authors :: J. Simonsen
N. Thulstrup
M. Vestergaard Kusk
P. Ingemann Nielsen
Source :: International Journal of Infectious Diseases, Vol 101, Iss, Pp 471-472 (2020)
Publication Year :: 2020
Publisher :: Elsevier BV, 2020.

Subjects :: Microbiology (medical)
Infectious Diseases
Booster (rocketry)
business.industry
Immunogenicity
Medicine
lcsh:RC109-216
General Medicine
business
Virology
Inactivated polio vaccine
lcsh:Infectious and parasitic diseases

Tools